Speaker Profile
Ph.D., President and CEO, Caribou Bio
Biography
Dr. Haurwitz is a co-founder of Caribou Biosciences and has been its president and chief executive officer and a director since the company’s inception in 2011. She is an inventor on patents and patent applications covering multiple CRISPR-based technologies, and has co-authored several scientific papers in high-impact journals characterizing CRISPR-Cas systems. In 2014, she was named by Forbes Magazine to the “30 Under 30” list in Science and Healthcare, and in 2016, Fortune Magazine named her to the “40 Under 40” list of the most influential young people in business. In 2018, the Association for Women in Science recognized Dr. Haurwitz with the annual Next Generation Award. She serves on the board of directors for Biotechnology Innovation Organization (BIO). Dr. Haurwitz earned an AB in biological sciences from Harvard College and a PhD in molecular and cell biology from the University of California, Berkeley.
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
Catriona Jamieson, UCSD
Opening talk
• Catriona Jamieson, UCSD
PMWC Award Ceremony
• Judy Faulkner, Epic
• Alexis C. Komor, UCSD
What’s Next at Epic?
• Judy Faulkner, Epic
• Peter DeVault, Epic
RNA Therapeutics Beyond mRNA: siRNA, ASOs, and snRNA
• Chair: Alexis C. Komor, UCSD
• Niren Murthy, UC Berkeley
• Gene Yeo, UCSD
• Reuben Harris, UT Health San Antonio
Stem Cell-Targeted Therapeutics: Small Molecules & Biologics
• Chair: Catriona Jamieson, UCSD
• Irving L. Weissman, Stanford
Space-Omics & Stem-Cell Adaptation
• Chair: Catriona Jamieson, UCSD
• Alysson Muotri, UCSD
In Vivo Gene Therapies
• Chair: Gene Yeo, UCSD
• Mark A Kay, Stanford
• David Schaffer, UC Berkeley
Diagnostics, Prognostics, and Patient Stratification
• Chair: Ezra Cohen, Tempus
• Gudrun Stengel, Alida Biosciences
• Jarret Glasscock, Cofactor Genomics
• "Phil Febbo, Veracyte
Bioprinting Transplantable Liver: mRNA-Driven Multi-Lineage Differentiation from Autologous iPSCs
• Jiwu Wang, The Scintillon Institute
A New Era in Heart Failure Treatment: Delivering on the Promise of iPSC-Derived Cardiomyocyte Therapy
• Eugene Wang, Help Therapeutics
Closing Talk
• Catriona Jamieson, UCSD
